| # | Drug | Count |
|---|---|---|
| 0 | NIRAPARIB | 131 |
| 1 | CARBOPLATIN | 130 |
| 2 | OLAPARIB | 109 |
| 3 | PACLITAXEL | 84 |
| 4 | BEVACIZUMAB | 72 |
| 5 | GEMCITABINE HYDROCHLORIDE | 49 |
| 6 | GEMCITABINE | 42 |
| 7 | CISPLATIN | 38 |
| 8 | DOXORUBICIN HYDROCHLORIDE | 23 |
| 9 | TOPOTECAN | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | 1 | 0.0263 |
| 1 | OLAPARIB | 109 | 0.0127 |
| 2 | NIRAPARIB | 131 | 0.0102 |
| 3 | CHERYLEE MD SENSITIVE SKIN CARE TRUELIPIDS DOUBLE ACTION BOO-BOO BUM | 3 | 0.0078 |
| 4 | FERRIC PYROPHOSPHATE | 1 | 0.0067 |
| 5 | CAMPHOR AND MENTHOL | 1 | 0.0066 |
| 6 | PANTHENOL | 1 | 0.0050 |
| 7 | WHITE PETROLATUM | 3 | 0.0045 |
| 8 | TOPOTECAN HYDROCHLORIDE | 20 | 0.0038 |
| 9 | POVIDONE IODINE 10% | 2 | 0.0037 |
| # | Drug class | Count |
|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 234 |
| 1 | Platinum-based Drug [EPC] | 141 |
| 2 | Microtubule Inhibitor [EPC] | 95 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 72 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 42 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| 6 | Topoisomerase Inhibitor [EPC] | 27 |
| 7 | Alkylating Drug [EPC] | 22 |
| 8 | Aromatase Inhibitor [EPC] | 22 |
| 9 | Corticosteroid [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 234 | 0.0109 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0012 |
| 2 | Melatonin Receptor Agonist [EPC] | 10 | 0.0010 |
| 3 | Microtubule Inhibitor [EPC] | 95 | 0.0009 |
| 4 | Platinum-based Drug [EPC] | 141 | 0.0009 |
| 5 | Antiseptic [EPC] | 2 | 0.0006 |
| 6 | Topoisomerase Inhibitor [EPC] | 27 | 0.0006 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 72 | 0.0006 |
| 8 | Sulfonamide Antibacterial [EPC] | 1 | 0.0004 |
| 9 | Phenothiazine [EPC] | 6 | 0.0003 |